Drug Type siRNA |
Synonyms PNPLA3 siRNA, LY 3849891, LY3849891 |
Target |
Mechanism PNPLA3 modulators(1-acylglycerol-3-phosphate O-acyltransferase modulators), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic dysfunction-associated steatotic liver disease | Phase 1 | US | 08 Jun 2022 | |
Metabolic dysfunction-associated steatotic liver disease | Phase 1 | JP | 08 Jun 2022 |